Sentence examples for categorical point from inspiring English sources

The concierge is making a categorical point about furniture.

Scarano had offered to meet me at Vere 26, after a long period of litigation-­related silence, in order to make a categorical point: that in his own scaled-down, pragmatic, outer-borough way, he, too, deserved to be counted as an artist.

To use a well-known metaphor: from a categorical point of view, Neurath's ship has become a spaceship.

Indeed, from a categorical point of view, a Cartesian product in set theory, a direct product of groups (Abelian or otherwise), a product of topological spaces, and a conjunction of propositions in a deductive system are all instances of a categorical product characterized by a universal property.

Modeling exposure as a simple continuous term appears to underestimate the exposure response relationship suggested by the categorical point estimates from corresponding log RR and linear RR models.

Modeling log-transformed exposure produces log RR and linear RR model estimates that conform reasonably well to the categorical point estimates, but the exposure response curve is very steep in the low-dose region.

For categorical end point modeling, M t) in Eq. 1 needs to be chosen as a function of drug exposure.

In some analyses, the lowest categorical cut point was set at 4.5 fibers/cc-years [i.e., a worker's cumulative lifetime exposure if exposed to asbestos fibers at the current OSHA standard of 0.1 fibers/cc over a 45-year working life (U.S. Department of Labor 2006)].

Because ACR20, ACR50, and ACR70 indicate different levels of the same disease improvement, they can be combined into one ordered categorical end point, called ACR, having four possible outcomes: ACR = 0, if achieving ACR70; ACR = 1, if achieving ACR50 but not ACR70; ACR = 2, if achieving ACR20 but not ACR50; and ACR = 3, if not achieving ACR20.

Of the eight categorical time points, only the morning 2-h postprandial time point was significantly different with combined LY2605541 (154.2 ± 2.9 mg/dL [8.6 ± 0.2 mmol/L]) versus GL (165.2 ± 4.3 mg/dL [9.2 ± 0.2 mmol/L], P = 0.034).

The efficacy of rituximab versus placebo was analysed using the Cochran Mantel–Haenszel test for categorical end points and analysis of variance (ANOVA) for continuous end points, adjusting for baseline stratification factors of rheumatoid factor (RF) status and region (USA vs non-USA).